Ryan White HIV/AIDS Program Performance Measures: How Do I Choose from so Many Options?
In-depth review of Policy Clarification Notice 15-02 requirements for performance measurement.
Resource (Conference Presentation) updated 09/14/2023
In-depth review of Policy Clarification Notice 15-02 requirements for performance measurement.
Resource (Conference Presentation) updated 09/14/2023
Resource updated 10/13/2023
Resource updated 10/24/2023
Resource updated 05/11/2023
Resource updated 12/19/2023
Resource updated 10/18/2023
Resource updated 05/10/2023
Resource updated 08/17/2023
Resource from the RWHAP Best Practices Compilation updated on 11/13/2023
Resource from the RWHAP Best Practices Compilation updated on 11/02/2023
RWHAP Technical Assistance Provider updated on 03/04/2024
Resource updated 08/17/2023
Resource updated 08/17/2023
Resource updated 09/14/2023
Resource from the RWHAP Best Practices Compilation updated on 11/01/2023
Resource updated 06/25/2024
Resource updated 08/17/2023
In a single-center restrospective cohort study, patients with extensive treatment experience and history of virologic failure and multi-drug resistance underwent simplification of ARV salvage regimens with a median pill burden reduction of six pills per day. This strategy led to high rates of virologic suppression.
Resource (Conference Presentation) updated 09/14/2023